


Eliksa Therapeutics
Biotechnology Research • Buckingham, Pennsylvania, United States • 1-10 Employees
Company overview
| Headquarters | 3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
Key Contacts at Eliksa Therapeutics
Jane Hollingsworth
Co-Founder & Executive Chair
Armen Karamanian
Co-Founder & Ceo
Eliksa Therapeutics Email Formats
Eliksa Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@eliksa.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@eliksa.com | 100% |
About Eliksa Therapeutics
Eliksa Therapeutics is a venture-backed biotechnology company with a proprietary cGMP production facility and a robust clinical pipeline addressing unmet medical needs in ocular and cardiovascular indications. Our lead candidate, ELK-003, is a novel multi-target biological modulating inflammation, cell recovery, and tissue healing. ELK-003 has proven to be safe and well-tolerated with 18,000+ human doses without any reported side effects.
Eliksa Therapeutics revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Eliksa Therapeutics has 5 employees across 3 departments.
Departments
Number of employees
Funding Data
Eliksa Therapeutics has never raised funding before.
Eliksa Therapeutics Tech Stack
Discover the technologies and tools that power Eliksa Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Frequently asked questions
4.8
40,000 users



